David T. Marshall

1.2k total citations
38 papers, 748 citations indexed

About

David T. Marshall is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, David T. Marshall has authored 38 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in David T. Marshall's work include Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). David T. Marshall is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). David T. Marshall collaborates with scholars based in United States and United Kingdom. David T. Marshall's co-authors include Elizabeth Garrett‐Mayer, Thomas E. Keane, Stephen J. Ramey, Stephen J. Savage, James Turner, Wesley E. Bolch, Bruce W. Hollis, Steven G Swarts, Sebastiano Gattoni‐Celli and Mark S. Kindy and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

David T. Marshall

37 papers receiving 734 citations

Peers

Countries citing papers authored by David T. Marshall

Since Specialization

Citations

This map shows the geographic impact of David T. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Marshall more than expected).

Fields of papers citing papers by David T. Marshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David T. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Marshall. The network helps show where David T. Marshall may publish in the future.

Co-authorship network of co-authors of David T. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of David T. Marshall. A scholar is included among the top collaborators of David T. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David T. Marshall. David T. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331 2021 ·Journal of Clinical Oncology ·Leonard A. Mattano, Meenakshi Devidas, Kelly W. Maloney, Cindy Wang, Alison M. Friedmann, Patrick J. Buckley, Michael J. Borowitz, Andrew J. Carroll, Julie M. Gastier‐Foster, Nyla A. Heerema, Nina S. Kadan‐Lottick, Yousif Matloub, David T. Marshall, Linda C. Stork, Mignon L. Loh, Elizabeth A. Raetz, Brent L. Wood, Stephen P. Hunger, William L. Carroll, Naomi Winick	22
2	S-Glutathionylated Serine Proteinase Inhibitors as Biomarkers for Radiation Exposure in Prostate Cancer Patients 2019 ·Scientific Reports ·Leilei Zhang, Jie Zhang, Zhiwei Ye, Yefim Manevich, Danyelle M. Townsend, David T. Marshall, Kenneth D. Tew	9
3	Pretreatment albumin may aid in patient selection for intrahepatic Y-90 microsphere transarterial radioembolization (TARE) for malignancies of the liver 2017 ·Journal of Gastrointestinal Oncology ·(unknown), Thomas H. Beckham, Samuel Lewis Cooper, (unknown), Mike B. Anderson, Marcelo Guimarães, Ricardo Yamada, David T. Marshall	6
4	The impact of metabolic syndrome on outcome and response to neoadjuvant chemoradiation in locally advanced rectal cancer patients 2016 ·International Journal of Surgery ·(unknown), Amy E. Wahlquist, Elizabeth G. Hill, David T. Marshall, Eric T. Kimchi, (unknown), E. Ramsay Camp	7
5	Results of the 2014 Survey of the Association of Directors of Radiation Oncology Programs (ADROP) 2015 ·Practical Radiation Oncology ·Ashesh B. Jani, David T. Marshall, Neha Vapiwala, (unknown), Márk Langer	2
6	Outstanding Outcome for Children with Standard Risk-Low (SR-Low) Acute Lymphoblastic Leukemia (ALL) and No Benefit to Intensified Peg-Asparaginase (PEG-ASNase) Therapy: Results of Children’s Oncology Group (COG) Study AALL0331 2014 ·Blood ·Leonard A. Mattano, Meenakshi Devidas, Alison M. Friedmann, Elizabeth A. Raetz, Mignon L. Loh, Patrick J. Buckley, Michael J. Borowitz, Andrew J. Carroll, Julie M. Gastier‐Foster, Nyla A. Heerema, Nina S. Kadan‐Lottick, Yousif Matloub, David T. Marshall, Linda C. Stork, Brent L. Wood, Naomi Winick, Stephen P. Hunger, William L. Carroll, Kelly W. Maloney	13
7	Excellent Event Free (EFS) and Overall Survival (OS) For Children With Standard Risk Acute Lymphoblastic Leukemia (SR ALL) Despite The Absence Of a Significant Impact On Outcome With The Addition Of An Intensified Consolidation: Results Of Children’s Oncology Group (COG) AALL0331 2013 ·Blood ·Kelly W. Maloney, Meenakshi Devidas, Leonard A. Mattano, Alison M. Friedmann, Patrick J. Buckley, Michael J. Borowitz, Andrew J. Carroll, Julie M. Gastier‐Foster, Nyla A. Heerema, Nina S. Kadan‐Lottick, Mignon L. Loh, Yousif Matloub, David T. Marshall, Linda C. Stork, Elizabeth A. Raetz, Brent L. Wood, Naomi Winick, Stephen P. Hunger, William L. Carroll	9
8	Phase I Trial of Weekly Docetaxel, Total Androgen Blockade, and Image-Guided Intensity-Modulated Radiotherapy for Localized High-Risk Prostate Adenocarcinoma 2013 ·Clinical Genitourinary Cancer ·David T. Marshall, Stephen J. Ramey, Ali‐Reza Golshayan, Thomas E. Keane, Andrew S. Kraft, Uzair B. Chaudhary	7
9	Vitamin D3 supplementation, low-risk prostate cancer, and health disparities 2012 ·The Journal of Steroid Biochemistry and Molecular Biology ·Bruce W. Hollis, David T. Marshall, Stephen J. Savage, Elizabeth Garrett‐Mayer, Mark S. Kindy, Sebastiano Gattoni‐Celli	26
10	Adjuvant Radiotherapy and Lymph Node Status for Pancreatic Cancer 2012 ·American Journal of Clinical Oncology ·(unknown), Amy E. Wahlquist, Elizabeth Garrett‐Mayer, Ravi Shridhar, (unknown), David T. Marshall	23
11	Vitamin D ₃ Supplementation at 4000 International Units Per Day for One Year Results in a Decrease of Positive Cores at Repeat Biopsy in Subjects with Low-Risk Prostate Cancer under Active Surveillance 2012 ·The Journal of Clinical Endocrinology & Metabolism ·David T. Marshall, Stephen J. Savage, Elizabeth Garrett‐Mayer, Thomas E. Keane, Bruce W. Hollis, Ronald L. Horst, (unknown), Mark S. Kindy, Sebastiano Gattoni‐Celli	91
12	Comparison of radiation treatment delivery for pancreatic cancer: Linac intensity‐modulated radiotherapy versus helical tomotherapy 2012 ·Journal of Medical Imaging and Radiation Oncology ·Robert B. Taylor, (unknown), Brian Jones, (unknown), D. G. McDonald, (unknown), (unknown), David T. Marshall	12
13	Adjuvant Radiotherapy and Lymph Node Status for Pancreatic Cancer: Results of a Study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data 2010 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Amy H. Wahlquist, Elizabeth Garrett‐Mayer, (unknown), David T. Marshall	5
14	Comparison of Intraoperatively Built Custom Linked Seeds Versus Loose Seed Gun Applicator Technique Using Real-Time Intraoperative Planning for Permanent Prostate Brachytherapy 2010 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Georgiana Onicescu, Harry S. Clarke, David T. Marshall	15
15	High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas 2009 ·Journal of Neuro-Oncology ·John M. Watkins, David T. Marshall, Sunil J. Patel, Pierre Giglio, Amy E. Herrin, Elizabeth Garrett‐Mayer, Joseph M. Jenrette	15
16	The multi-disciplinary management of high-risk prostate cancer 2009 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Ali‐Reza Golshayan, David T. Marshall, (unknown), Thomas E. Keane	19
17	Monte Carlo Simulations of Site-Specific Radical Attack to DNA Bases 2008 ·Radiation Research ·(unknown), Wesley E. Bolch, Steven G Swarts, James Turner, David T. Marshall	40
18	Preliminary results of a phase II neoadjuvant trial with gemcitabine/oxaliplatin and cetuximab followed by surgery or concurrent intensity modulated radiation therapy (IMRT) with capecitabine for patients with borderline resectable and unresectable nonmetastatic pancreatic cancer 2008 ·Journal of Clinical Oncology ·Uma Chaudhary, Vinay Gudena, (unknown), (unknown), Alberto J. Montero, James H. Brashears, David T. Marshall, Brenda J. Hoffman, Elizabeth Garrett‐Mayer, Nestor F. Esnaola	1
19	In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines 1999 ·British Journal of Cancer ·(unknown), R. Barbara Pedley, David T. Marshall, (unknown), A. J.W. Hilson, Marc C. Winslet, K E F Hobbs	13
20	Complications following radiotherapy and pelvic lymph node dissection for carcinoma of the cervix: report of a case. 1962 ·PubMed ·David T. Marshall, Henry Clay Frick	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact